Open access
PADL1NK-005 study design: a phase III trial of fetrastobart vedotin (Fetra-V) vs docetaxel in patients with previously treated tumor PD-L1-positive NSCLC.
Mehmet Altan
V. Navani
H. Kim
L. Sun
L. Paz-Ares
I. Chmielewska
Chien-Chung Lin
K. Cuppens
Ioannis Mountzios
Nir Peled
F. Cappuzzo
Bo Wang
Cai-Cun Zhou
N. Girard
Yi-Jia Wang
Sandra T. Asanin
Mo Huang
E. Garon
Medicine
Abstract
CLINICAL TRIAL REGISTRATION NCT07144280 (https://clinicaltrials.gov/study/NCT07144280).